期刊文献+

5-氟尿嘧啶作用人肝癌细胞系SMMC-7721后残存细胞中肿瘤干细胞比例增加 被引量:4

The proportion of tumor stem cells increases in the presence of 5-FU on human liver carcinoma SMMC-7721 cell line
暂未订购
导出
摘要 目的主要探讨5-氟尿嘧啶(5-FU)作用肝癌细胞系SMMC-7721后残余细胞中NCAM/CD56、ICAM-1/CD54、EpCAM、CD133及ABCG2阳性细胞表达率的变化。方法检测不同浓度5-FU作用于SMMC-7721细胞系前后细胞增殖能力的变化,流式细胞仪检测残存细胞的细胞周期分布以及5种表面标志物阳性细胞表达率的变化。结果不同浓度5-FU均可抑制SMMC-7721增殖。使用10μg/mL的5-FU浓度作用48 h进一步研究,SMMC-7721细胞周期各期细胞比例均较对照组有影响,且G0/G1、S和G2/M期5-FU作用前后差异有统计学意义(P<0.05),G0/G1期阻滞明显。5-FU处理使SMMC-7721 5种细胞表面标志物阳性细胞比例均明显升高,差异均具有统计学意义(P<0.05),阳性细胞比例均明显升高。结论上述实验提示肝癌干细胞逃避5-FU单药物的杀伤可能是临床上肝癌化疗失败和肿瘤复发的重要原因,同时,此实验方法可以作为肝癌干细胞富集的科研模型。 Objective To study the changes of NCAM/CD56,ICAM-1/CD54,EpCAM,CD133 and ABCG2 positive cells proportion in the presence of 5-FU on human liver carcinoma SMMC-7721 cell line. Methods Cell proliferation in different concentrations of 5-FU was evaluated by CCK-8(cell counting kit-8).Cell cycle and positive cells proportion of NCAM,ICAM-1,EpCAM,CD133,ABCG2 were measured by Flow Cytometry in an appropriate concentration of 5-FU. Results The proliferation of liver carcinoma cell was inhibited by different concentrations of 5-FU.The appropriate concentration of 5-FU was determined as 10 μg/mL with 48 h incubation.After treatment,G0/G1 phase cells increased from 46.617%±18.857% to 83.917%±12.996%.Whereas,S phase cells decreased from 50.510%±16.405% to 15.360%±13.517%;G2/M phase cells decreased from 2.872%±2.824% to 0.722%±0.711%.The proportion of G0/G1,S and G2/M stage compared with control group changed with statistic differences(P0.05).Meanwhile,positive cells proportion of cell surface makers NCAM,ICAM-1,EpCAM,CD133,ABCG2 increased from 0.6%±0;78.0%±0.9%;3.9%±0.1%;8.2%±0.6%;0.3%±0.1% to 7.2%±0.1%;94.6%±0.1%;5.4%±0.3%;17.5%±0.4%;1.8%±0.1%,respectively.The difference was significant(P0.05).NCAM,ICAM-1,EpCAM,CD133 and ABCG2 positive cells proportion increased in the presence of 5-FU on human liver carcinoma SMMC-7721 cell line. Conclusion It suggests that the escape mechanism of liver cancer stem cells in the presence of 5-FU is the major reason of chemotherapy failure clinically.Meanwhile,this experimental method could be a researchful model in enriching liver cancer stem cells.
出处 《胃肠病学和肝病学杂志》 CAS 2012年第3期224-228,共5页 Chinese Journal of Gastroenterology and Hepatology
基金 北京市教育委员会"人才强教"项目中青年骨干人才培养计划基金(PHR201008387)
关键词 肝癌 肿瘤干细胞 5-氟尿嘧啶 Liver carcinoma Cancer stem cells 5-fluorouracil
  • 相关文献

参考文献32

  • 1Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 2吴孟超.原发性肝癌治疗的进展[J].中华医学信息导报,2002,17(1):10-11. 被引量:6
  • 3Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,and canc-er stem cells[J].Nature,2001,414(6859):105-111.
  • 4Al-Hajj M,Clarke MF.Self-renewal and solid tumor stem cells[J].Oncogene,2004,23(43):7274-7282.
  • 5Scadden DT.Cancer stem cells refined[J].Nat Immunol,2004,5(7):701-703.
  • 6Morgan J,Jackson JD,Zheng X,et al.Substrate affinity of photosen-sitizers derived from chlorophyll-a:the ABCG2transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy[J].Mol Pharm,2010Sep1.
  • 7Sell S.Cellular origin of hepatocellular carcinomas[J].Semin Cell Dev Biol,2002,13(6):419-424.
  • 8Al-Hajj M,Wicha MS,Benito-Hernandez A,et al.Prospective identi-fication of tumorigenic breast cancer cells[J].Proc Natl Acad Sci U S A,2003,100(7):3983-3988.
  • 9Singh SK,Clarke ID,Hide T,et al.Cancer stem cells in nervous sys-tem tumors[J].Oncogene,2004,23(43):7267-7273.
  • 10Collins AT,Berry PA,Hyde C,et al.Prospective identification of tumorigenic prostate cancer stem cells[J].Cancer Res,2005,65(23):10946-10951.

二级参考文献30

  • 1CHEN Yong-bing,YAN Mao-lin,GONG Jian-ping,XIA Ren-pin,LIU Li-xin,LI Ning,LU Shi-chun,ZHANG Jing-guang,ZENG Dao-bing,XIE Jian-guo,YANG Jia-yin,YAN Lü-nan.Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1[J].Chinese Medical Journal,2007(8):703-707. 被引量:16
  • 2Abbott BL.ABCG2 (BCRP) expression in normal and malignant hematopoietic cells.Hematol Oncol,2003,21:115-130.
  • 3Haraguchi N,Utsunomiya T,Inoue H,et al.Characterization of a side population of cancer cells from human gastrointestinal system.Stem Cells,2006,24:506-513.
  • 4Singh SK,Clarke ID,Terasaki M.Identification of a cancer stem cell in human brain tumors.Cancer Res,2003,63:5821-5828.
  • 5Kondo T,Setoguchi T,Taga T.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.Proc Natl Acad Sci USA,2004,101:781-786.
  • 6Zhou S,Schuetz JD,Bunting KD,et al.The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.Nat Med,2001,7:1028-1034.
  • 7Hulspas R,Quesenberry PJ.Characterization of neurosphere cell phenotypes by flow cytometry.Cytometry,2000,40:245-250.
  • 8Bhattacharya S,Jackson JD,Das AV,et al.Direct identification and enrichment of retinal stem cells/progenitors by Hoechst dye efflux assay.Invest Ophthalmol Vis Sci,2003,44:2764-2773.
  • 9Asakura A.Stem cells in adult skeletal muscle.Trends Cardiovasc Med,2003,13:123-128.
  • 10Shimano K,Satake M,Okaya A,et al.Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporterABCG2/BCRP1.Am J Pathol,2003,163:3-9.

共引文献25

同被引文献46

  • 1林照亮,吴炎,戴少敏,吴盛州,龚梅金,张永顶,邱静,周其才.肿瘤干细胞及其Wnt信号通路在胃癌患者中的表达[J].黑龙江医学,2013,37(6):408-410. 被引量:4
  • 2Monika Olempska,Patricia Alice Eisenach,Ole Ammerpohl,Hendrik Ungefroren,Fred Fandrich,Holger Kalthoff.Detection of tumor stem cell markers in pancreatic carcinoma cell lines[J].Hepatobiliary & Pancreatic Diseases International,2007,6(1):92-97. 被引量:69
  • 3王忠强,郑启昌,黄文广,段秋红,王西明.褪黑素、顺铂协同抑制人肝癌细胞SMMC-7721的机制研究[J].华中科技大学学报(医学版),2004,33(5):569-572. 被引量:13
  • 4胡梅洁,曾晖,章永平,张曙,乔敏敏,付华,吴云林.苦参碱联合5-氟尿嘧啶对人胃癌裸鼠移植瘤的抑制作用[J].中华消化杂志,2005,25(4):219-221. 被引量:28
  • 5简志祥.原发性肝癌治疗的进展及展望[J].实用医学杂志,2007,23(6):773-775. 被引量:19
  • 6Heimberger AB, Sampson JH. The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients. Expert Opin Biol Ther. 2009;9(8):1087-1098.
  • 7Iacovelli R, Pietrantonio F, Palazzo A, et al. Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials. Br J Clin Pharmacol. 2014;78(6): 1228- 1237.
  • 8Lecluse LL, Spuls PI. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal. Br J Dermatol. 2015;172(1):8-10.
  • 9Yang L, Han S, Sun Y. An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial- mesenchymal transition and cancer stem cell expansion in human breast cancer cells. Biochem Biophys Res Commun. 2014;453(3):582-587.
  • 10Waki M, Ide Y, Ishizaki I, et al. Single-cell time-of-flight secondary ion mass spectrometry reveals that human breast cancer stem cells have significantly lower content of palmitoleic acid compared to their counterpart non-stem cancer cells. Biochimie. 2014;107 Pt A:73-77.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部